Literature DB >> 21234631

Cardiac tamponade and large pericardial effusions in systemic sclerosis: a report of four cases and a review of the literature.

James V Dunne1, Julie P Chou, Mohan Viswanathan, Pearce Wilcox, Simon H Huang.   

Abstract

Cardiac tamponade in systemic sclerosis is rare. We report four cases of SSc with hemodynamically significant pericardial effusions associated with pulmonary arterial hypertension, three of whom died, two following pericardiocentesis. Of 26 SSc cases reported in the literature with large pericardial effusions, seven were associated with PAH. Including our series, the mortality rate is 55%.The potential contributory role of PAH in the development of pericardial effusion and the management implications are explored. In SSc patients with hemodynamically significant pericardial effusions and severe pulmonary hypertension, initial stabilization of pulmonary artery pressure and right heart function with vasoactive therapy and then cautious pericardial drainage should be considered.

Entities:  

Mesh:

Year:  2011        PMID: 21234631     DOI: 10.1007/s10067-010-1667-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  35 in total

1.  Echocardiographic features of progressive systemic sclerosis (PSS). Correlation with hemodynamic and postmortem studies.

Authors:  J W Smith; P J Clements; J Levisman; D Furst; M Ross
Journal:  Am J Med       Date:  1979-01       Impact factor: 4.965

2.  Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension.

Authors:  Micah R Fisher; Paul R Forfia; Elzbieta Chamera; Traci Housten-Harris; Hunter C Champion; Reda E Girgis; Mary C Corretti; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2009-01-22       Impact factor: 21.405

3.  Pericardial fluid analysis in scleroderma (systemic sclerosis).

Authors:  D D Gladman; D A Gordon; M B Urowitz; H L Levy
Journal:  Am J Med       Date:  1976-06       Impact factor: 4.965

4.  Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis.

Authors:  Janet E Pope; Peter Lee; Murray Baron; James Dunne; Douglas Smith; Peter S Docherty; Arthur Bookman; Maysan Abu-Hakima
Journal:  J Rheumatol       Date:  2005-07       Impact factor: 4.666

5.  Left ventricular tamponade: echocardiographic and hemodynamic manifestations.

Authors:  R T Lee; S J Bhatia; J M Kirshenbaum; P L Friedman
Journal:  Clin Cardiol       Date:  1989-02       Impact factor: 2.882

6.  Pericardial disease in scleroderma: prognosis and clinical associations.

Authors:  J Wefuan; S L Aaron
Journal:  Clin Exp Rheumatol       Date:  1993 Sep-Oct       Impact factor: 4.473

7.  Pericardiocentesis.

Authors:  J G Krikorian; E W Hancock
Journal:  Am J Med       Date:  1978-11       Impact factor: 4.965

8.  Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension.

Authors:  Ronald J Raymond; Alan L Hinderliter; Park W Willis; David Ralph; Edgar J Caldwell; William Williams; Neil A Ettinger; Nicholas S Hill; Warren R Summer; Bennett de Boisblanc; Todd Schwartz; Gary Koch; Linda M Clayton; Maria M Jöbsis; James W Crow; Walker Long
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

9.  Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction.

Authors:  B H Bulkley; R L Ridolfi; W R Salyer; G M Hutchins
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

Review 10.  The heart in scleroderma.

Authors:  Hunter C Champion
Journal:  Rheum Dis Clin North Am       Date:  2008-02       Impact factor: 2.670

View more
  10 in total

1.  Pericardial effusion in pulmonary arterial hypertension.

Authors:  Sandeep Sahay; Adriano R Tonelli
Journal:  Pulm Circ       Date:  2013-11-22       Impact factor: 3.017

Review 2.  Systemic sclerosis and the heart: current diagnosis and management.

Authors:  Chintan S Desai; Daniel C Lee; Sanjiv J Shah
Journal:  Curr Opin Rheumatol       Date:  2011-11       Impact factor: 5.006

Review 3.  Update on assessment and management of primary cardiac involvement in systemic sclerosis.

Authors:  Vasiliki-Kalliopi Bournia; Christos Tountas; Athanase D Protogerou; Stylianos Panopoulos; Sophie Mavrogeni; Petros P Sfikakis
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

4.  Pulmonary hypertension complicated by pericardial effusion: a single center experience.

Authors:  Gregory R Honeycutt; Zeenat Safdar
Journal:  Ther Adv Respir Dis       Date:  2012-12-20       Impact factor: 4.031

5.  Recurrent cardiac tamponade in a young woman.

Authors:  Shobha Manish Itolikar; Santosh Salagre; Sanat Phatak; Manish Itolikar
Journal:  BMJ Case Rep       Date:  2013-11-29

Review 6.  A GPS map for pulmonary hypertension: a review of imaging modalities.

Authors:  Jinghui Li; Ashley Lee; Yingsheng Cheng
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

Review 7.  Cardiac complications in systemic sclerosis: early diagnosis and treatment.

Authors:  Liu-Yan Nie; Xiao-Dong Wang; Ting Zhang; Jing Xue
Journal:  Chin Med J (Engl)       Date:  2019-12-05       Impact factor: 2.628

8.  Atypical presentation of cardiac tamponade in pulmonary hypertension: A case report and review of the literature.

Authors:  Zahra Ansari Aval; Seyed Mohsen Mirhosseini; Sepideh Jafari Naeini
Journal:  Clin Case Rep       Date:  2021-12-13

Review 9.  Cardiovascular Imaging for Systemic Sclerosis Monitoring and Management.

Authors:  Peter Glynn; Sarah Hale; Tasmeen Hussain; Benjamin H Freed
Journal:  Front Cardiovasc Med       Date:  2022-03-31

10.  Clinically Symptomatic Pericardial Effusions in Hospitalized Systemic Sclerosis Patients: Demographics and Management.

Authors:  Hitomi Hosoya; Chris T Derk
Journal:  Biomed Res Int       Date:  2018-06-04       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.